SC 13D

Company

Nautilus Biotechnology, Inc.

Filed

June 16, 2021

Accession Number

0001628280-21-012358

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →